Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes
Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
05/2003
05/27/2003US6569672 Methods and apparatus in which pressure provides precise control over the timing and preferably synchronization of chemical reactions, particularly enzymatic reactions.
05/27/2003US6569667 Useful as modulating agents in regulating cellular growth, proliferation, differentiation, or migration
05/27/2003US6569666 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor
05/27/2003US6569665 Genetic engineering; enzymatic inhibitor screening; use of calpain inhibitors in treatment of neurodegenerative disease
05/27/2003US6569664 Tumor necrosis factor (TNF); enzyme purification and characterization; regulation of TNF for use in treatment of inflammatory diseases and conditions
05/27/2003US6569663 Modified amino acid sequences; decreased immunogenicity; subtilisin; mutant genes; use in cleaning and personal care compositions
05/27/2003US6569661 Recombinant α-L-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof
05/27/2003US6569660 Human DNase
05/27/2003US6569659 Basidiomycetes; consensus sequences; use in industrial applications
05/27/2003US6569658 Proteins and nucleic acids which have an effect on or are related to cell cycle regulation; use in assays screening for cell cycle modulators and as therapeutics
05/27/2003US6569657 Isolated nucleic acids molecules encoding novel aldehyde dehydrogenase-like proteins; use in diagnosis of disease conditions involving genetically altered enzyme
05/27/2003US6569656 Synthases
05/27/2003US6569650 Process for the fermentative preparation of metabolic products and for the nucleotide sequences encoding for the sod gene
05/27/2003US6569649 Compositions and methods for saccharide synthesis
05/27/2003US6569646 Process for the production of an enzyme preparation containing xylanase and carboxymethyl cellulase from termitomyces clypeatus having accession no 11CB-411
05/27/2003US6569645 IL-17 homologous polypeptides and therapeutic uses thereof
05/27/2003US6569644 Isolated and purified 12R-lipoxygenase protein and nucleic acids
05/27/2003US6569643 Expression vector for use as tool in genetic engineering
05/27/2003US6569641 Which can modify transcription, replication or stability of a DNA sequence; producing stochastically generated polynucleotide sequences; expression vectors
05/27/2003US6569638 Method for screening compounds for the treatment of neoplasia
05/27/2003US6569623 Genetic screening methods
05/27/2003US6569622 Nucleic acids encoding a protein conferring an inducible resistance to glycopeptide, particularly in gram-positive bacteria
05/27/2003US6569617 Identifying a chemical agent which alters activity of a protein encoded by a mammalian gene, modifying the phenotypic alteration
05/27/2003US6569429 Isolated polypeptide comprising the amino acid residues 1 to 344 of (SEQ ID NO: 2); systemic lupus erythematosus; pulmonary disease or disorder
05/27/2003US6569340 Manufacturing universal plasma from blood comprising serological Group A and/or Group B antibodies; contacting with a chromatography resin comprising corresponding Group A and/or Group B antigen
05/27/2003CA2173105C Protease-containing cleaning compositions
05/27/2003CA2140866C Use of inhibitors of fatty acid synthesis for treating cancer
05/27/2003CA2024309C Pharmaceutical compositions comprising modified and unmodified plasminogen activators and uses thereof
05/23/2003WO2002042475A1 Gene hd3a inducing flowering of plant and utilization thereof
05/22/2003WO2003042693A2 Method for measuring intracellular atp and/or gene expression
05/22/2003WO2003042391A1 Method for enhancing the efficiency of an enzymatic purification process
05/22/2003WO2003042390A1 Mammalian protein phosphatases
05/22/2003WO2003042389A1 Genes coding for glucose-6-phosphate-dehydrogenase proteins
05/22/2003WO2003042383A1 Dna synthesis promoters, dna polymerase-associated factors and utilization thereof
05/22/2003WO2003042382A1 ES CELLS WITH ENHANCED RNAi EFFECT
05/22/2003WO2003042381A1 Three-dimensional structure of prostaglandin d synthase and utilization thereof
05/22/2003WO2003042380A2 Materials and methods for reducing oxalate concentrations in fluids
05/22/2003WO2003042379A2 A new disintegrin and metalloproteinase with thrombospondin type i repeats polynucleotide and its encoded polypeptide
05/22/2003WO2003042378A1 Sulphatases and use thereof
05/22/2003WO2003042371A2 55053, a novel human eukaryotic kinase and uses therefor
05/22/2003WO2003042369A2 Cellular kinase targets and inhibitors, and methods for their use
05/22/2003WO2003042362A2 PGC-1β, A NOVEL PGC-1 HOMOLOGUE AND USES THEREFOR
05/22/2003WO2003042358A2 Methods of using 48149, a human aminopeptidase family member
05/22/2003WO2003042357A2 Enzymes
05/22/2003WO2003042354A2 Abrogen polypeptides, nucleic acids encoding them and methods for using them to inhibit angiogenesis
05/22/2003WO2003042239A1 Peptides inhibiting signaling by ras-like gtpases
05/22/2003WO2003042236A1 Process for producing concentrated/purified protein using clay mineral composition
05/22/2003WO2003041830A2 Macroporous gel, its preparation and its use
05/22/2003WO2003041729A1 Ptp1b inhibitors and ligands
05/22/2003WO2003041680A1 Topical compositions containing enzymes stabilized with inhibitors
05/22/2003WO2003041635A2 Methods and compositions for therapeutic treatment of cathepsin k complex-mediated disorders
05/22/2003WO2003041490A2 Novel isoamylases and associated methods and products
05/22/2003WO2003031631A8 Modification of plant responses to salt
05/22/2003WO2003012089A3 Crystal structure of beta-site app cleaving enzyme (bace) and use thereof
05/22/2003WO2003004652A3 Use of a tyrosine recombinase for genetic engineering
05/22/2003WO2003000874A3 Regulation of human serine/threonine protein kinase nek3
05/22/2003WO2002081625A3 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
05/22/2003WO2002077265A3 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding these human drug-metabolizing proteins, and uses thereof
05/22/2003WO2002061062A3 Human protein kinase n-like polypeptide and uses thereof
05/22/2003WO2002050283A3 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
05/22/2003WO2002044722A3 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes
05/22/2003WO2002040690A3 Production of medium chain length polyhydroxyalkanoates from fatty acid biosynthetic pathways
05/22/2003WO2002036780A3 Stearoyl-coa desaturase gene promoter
05/22/2003WO2002033059A3 Gnk interacting amino acid decarboxylase and methods of use thereof
05/22/2003WO2002022776A9 Human coagulation factor vii variants
05/22/2003WO2002018617A3 Carotenoid production by recombinant, c1-metabolizing methanothropic bacteria
05/22/2003US20030097692 Plants with imidazolinone-resistant ALS
05/22/2003US20030097690 For regulating expression of heterologous nucleotide sequences in a plant
05/22/2003US20030097688 Starch synthase isoform V
05/22/2003US20030097686 Growing a transgenic predominantly unsaturated temperate zone oilseed crop plant species to seed, wherein plant comprises a recombinant DNA construct integrated into the genome of its cells, harvesting a plant seed having a modified fatty acid
05/22/2003US20030097684 Using to enhance resistance of plants to pests
05/22/2003US20030097682 Genetically modified plants with enhanced resistance to fungal diseases and a method of production thereof
05/22/2003US20030097681 Plant is cultivated in an environment contaminated with the hazardous chemical substances for decomposing and removing hazardous chemical substances
05/22/2003US20030097680 Transgenic plant
05/22/2003US20030097679 Production of ascorbic acid in plants
05/22/2003US20030097678 Cultivating a transgenic dicotyledonous plant having an expression system inducible during the germination; placing transgenic dicotyledonous seeds comprising expression system integrated into plant genome in medium to germinate
05/22/2003US20030097677 Transgenic high tryptophan plants
05/22/2003US20030097676 Plant acyl-CoA synthetases
05/22/2003US20030097675 Cell cycle stress-related proteins and methods of use in plants
05/22/2003US20030097673 Enhanced accumulation of trehalose in plants
05/22/2003US20030097669 Erk-5 deficient animals and methods of inhibiting angiogenesis through the inhibition of Erk-5
05/22/2003US20030097668 Compositions and methods for the treatment and diagnosis of cardiovascular disease
05/22/2003US20030097667 For therapy of Alzheimers disease, diagnosis
05/22/2003US20030097665 To produce phosphorylated lysosomal proteins which are incorporated into pharmaceutical formulations for use in enzyme replacement therapy
05/22/2003US20030096970 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders
05/22/2003US20030096969 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders
05/22/2003US20030096967 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/22/2003US20030096965 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/22/2003US20030096964 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders
05/22/2003US20030096963 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/22/2003US20030096955 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cancer and nervous system disorders
05/22/2003US20030096954 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cancer and nervous system disorders
05/22/2003US20030096857 Novel antidiabetic agents
05/22/2003US20030096816 Such as 2-methylsulfanyl-5-(2-phenylamino-pyrimidin-4-yl)-4-p-tolyl-thiophene-3 -carbonitrile; antiproliferative agents; stents
05/22/2003US20030096793 Inhibit protease enzymes; Benzyl 5-(benzoylamino)-4,4-dihydroxy-7- methyl-4-sila-octanamide, for example can be used to inhibit HIV protease in the treatment of AIDS
05/22/2003US20030096784 Oligoribonucleotides and oligoribonucleosides that have subsequences of 2'-pentoribofuranosyl nucleosides that activate dsRNase (double stranded RNAase)
05/22/2003US20030096769 Genetic molecules capable of modulating growth factor interaction with its receptor on epidermal keratinocytes
05/22/2003US20030096744 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/22/2003US20030096742 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/22/2003US20030096723 Low temperature activation; washing detergents, high washing power
1 ... 812 813 814 815 816 817 818 819 820 821 822 823 824 825 826 827 828 829 830 831 832 ... 1416